From what you say then is there is only one option because option two will also have consolidation. Then the only difference really is find a new project or stay with what they have.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025